CD8A and neoplasm: Immunotyping of the tumor revealed a remarkable enhancement in the immune profile of the collagenase-treated group, characterized by improved antitumor immunity (Fig. 1V–Y), a significant increase in CD8+ T cell proportion, a decrease in Treg proportion, and a marked reduction of MDSC levels.